Inventor
BEDIAN VAHE
US34 patents
⚠️ This page may combine multiple inventors who share the name “BEDIAN VAHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN FREMONT INC
8 patentsUS7626012B2Dec 1, 2009
Nucleic acid molecules which encode antibodies that bind CD40
AMGEN FREMONT INC53 citations98
US7618633B2Nov 17, 2009
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
AMGEN FREMONT INC63 citations98
US7498420B2Mar 3, 2009
Antibodies to c-Met
AMGEN FREMONT INC60 citations96
US7728113B2Jun 1, 2010
Methods of treating arthritic conditions with antibodies to M-CSF
AMGEN FREMONT INC21 citations92
US8821869B2Sep 2, 2014
Treatment methods using c-Met antibodies
AMGEN FREMONT INC13 citations91
US7537762B2May 26, 2009
Human monoclonal antibodies to activin receptor-like kinase-1
AMGEN FREMONT INC34 citations89
US10280219B2May 7, 2019
Antibodies to M-CSF
AMGEN FREMONT INC1 citations72
US9718883B2Aug 1, 2017
Antibodies to M-CSF
AMGEN FREMONT INC0 citations51
BEDIAN VAHE
4 patentsUS8388971B2Mar 5, 2013
Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
BEDIAN VAHE32 citations95
US8192738B2Jun 5, 2012
Targeted antibodies directed to DLL4
BEDIAN VAHE16 citations92
US8507656B2Aug 13, 2013
Stabilized angiopoietin-2 antibodies and uses thereof
BEDIAN VAHE6 citations81
US8188249B2May 29, 2012
Nucleic acid molecules encoding antibodies to M-CSF
BEDIAN VAHE2 citations61
PFIZER
3 patentsVIRIDIAN THERAPEUTICS INC
3 patentsUS11548951B1Jan 10, 2023
Compositions and methods for treatment of thyroid eye disease
VIRIDIAN THERAPEUTICS INC7 citations80
US12404335B2Sep 2, 2025
Compositions and methods for treatment of thyroid eye disease
VIRIDIAN THERAPEUTICS INC2 citations69
US12595309B2Apr 7, 2026
Compositions and methods for treatment of thyroid eye disease
VIRIDIAN THERAPEUTICS INC0 citations57